Featured Research

from universities, journals, and other organizations

Genetic trigger of depression identified: Potential target for novel class of therapeutic agents

Date:
October 18, 2010
Source:
Yale University
Summary:
Researchers have found a gene that seems to be a key contributor to the onset of depression and is a promising target for a new class of antidepressants.

A called MKP-1 seems to be a key contributor to the onset of depression and is a promising target for a new class of antidepressants.
Credit: iStockphoto/Dieter Hawlan

Yale University researchers have found a gene that seems to be a key contributor to the onset of depression and is a promising target for a new class of antidepressants, they report Oct. 17 in the journal Nature Medicine.

"This could be a primary cause, or at least a major contributing factor, to the signaling abnormalities that lead to depression," said Ronald S. Duman, professor of psychiatry and pharmacology at Yale and senior author of the study.

Scientists have had a difficult time pinning down the cause of depression, which afflicts almost 16 percent of Americans in any given year and carries an annual economic burden of $100 billion.

Symptoms of depression vary widely among individuals. Most now believe that multiple physiological processes are involved in major depressive disorder. That explains why people respond differently to most commonly prescribed antidepressants, which work by manipulating the uptake of the neurotransmitter serotonin. However, as many as 40 percent of depressed patients do not respond to currently available medications, which take weeks to months to produce a therapeutic response.

Duman's team did whole genome scans on tissue samples from 21 deceased individuals who had been diagnosed with depression and compared gene expression levels to those of 18 individuals who had not been diagnosed with depression. They found that one gene called MKP-1 was increased more than two-fold in the brain tissues of depressed individuals.

This was particularly exciting, say the researchers, because the gene inactivates a molecular pathway crucial to the survival and function of neurons and its impairment has been implicated in depression as well as other disorders. Duman's team also found that when the MKP-1 gene is knocked out in mice, the mice become resilient to stress. When the gene is activated, mice exhibit symptoms that mimic depression.

The finding that a negative regulator of a key neuronal signaling pathway is increased in depression also identifies MKP-1 as a potential target for a novel class of therapeutic agents, particularly for treatment resistant depression.

Other Yale authors include Vanja Duric, Mounira Banasr, Pawel Licznerski, Heath D Schmidt, Arthur A Simen and Samuel S Newton.

The work was funded by the U.S. Health Service and State of Connecticut, Connecticut Mental Health Center.


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Vanja Duric, Mounira Banasr, Pawel Licznerski, Heath D Schmidt, Craig A Stockmeier, Arthur A Simen, Samuel S Newton, Ronald S Duman. A negative regulator of MAP kinase causes depressive behavior. Nature Medicine, 2010; DOI: 10.1038/nm.2219

Cite This Page:

Yale University. "Genetic trigger of depression identified: Potential target for novel class of therapeutic agents." ScienceDaily. ScienceDaily, 18 October 2010. <www.sciencedaily.com/releases/2010/10/101017133639.htm>.
Yale University. (2010, October 18). Genetic trigger of depression identified: Potential target for novel class of therapeutic agents. ScienceDaily. Retrieved August 27, 2014 from www.sciencedaily.com/releases/2010/10/101017133639.htm
Yale University. "Genetic trigger of depression identified: Potential target for novel class of therapeutic agents." ScienceDaily. www.sciencedaily.com/releases/2010/10/101017133639.htm (accessed August 27, 2014).

Share This




More Mind & Brain News

Wednesday, August 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Newsy (Aug. 26, 2014) A study published in the journal "Neurology" interviewed more than 19,000 people and found 15 percent suffer from being "sleep drunk." Video provided by Newsy
Powered by NewsLook.com
Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Newsy (Aug. 26, 2014) A new study found fewer deaths from prescription drug overdoses in states that have legalized medical marijuana. But experts disagree on the results. Video provided by Newsy
Powered by NewsLook.com
Heart Group: E-Cigarettes May Help Smokers Quit

Heart Group: E-Cigarettes May Help Smokers Quit

AP (Aug. 25, 2014) The American Heart Association's first policy statement on electronic cigarettes backs them as a last resort to help smokers quit and calls for more regulation to keep them away from youth. (Aug. 25) Video provided by AP
Powered by NewsLook.com
Doctors Push For Later Start Times As School Year Kicks Off

Doctors Push For Later Start Times As School Year Kicks Off

Newsy (Aug. 25, 2014) The American Academy of Pediatrics is the latest group pushing for middle schools and high schools to start later, for the sake of their kids. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins